Regression of sporadic CNS hemangioblastomas with belzutifan
Braeden D Newton1, Amit R Persad2, Julia Radic2
1Division of Neurosurgery, University of Saskatchewan, Saskatoon, SK, Canada. braeden.newton@usask.ca.
Journal of Neuro-Oncology
|July 17, 2025
Abstract
No abstract available in PubMed .
More Related Videos
06:15Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
27.5K
09:43Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Published on: May 17, 2017
11.7K
